| Identification | Back Directory | [Name]
1H-Dipyrrolo[1,2-a:2',3'-d]pyrimidine-1-acetamide, 3-[5-(aminocarbonyl)-2,3-difluoro-4-hydroxyphenyl]-N-[3-chloro-6-[(2S)-2,4-dimethyl-1-piperazinyl]-2-fluoro-4-pyridinyl]-4,6,7,8-tetrahydro-4-oxo- | [CAS]
2360625-97-2 | [Synonyms]
OICR12694
1H-Dipyrrolo[1,2-a:2',3'-d]pyrimidine-1-acetamide, 3-[5-(aminocarbonyl)-2,3-difluoro-4-hydroxyphenyl]-N-[3-chloro-6-[(2S)-2,4-dimethyl-1-piperazinyl]-2-fluoro-4-pyridinyl]-4,6,7,8-tetrahydro-4-oxo- | [Molecular Formula]
C29H28ClF3N8O4 | [MOL File]
2360625-97-2.mol | [Molecular Weight]
645.03 |
| Hazard Information | Back Directory | [Uses]
OICR12694 (JNJ-65234637) is an orally active inhibitor of B cell lymphoma 6 (BCL6)[1]. | [References]
[1] Mamai A, et al. Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor. ACS Med Chem Lett. 2023 Jan 12;14(2):199-210. DOI:10.1021/acsmedchemlett.2c00502 |
|
|